Drreddys Laboratories | RDY - بدهی های جاری





بدهی های جاری تغییر دادن تاریخ
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Cipla INR 62.97B 8.13B 2025-09
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lonza CHF 3.57B 421M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Richter Gedeon HUF 171.18B 10.98B 2025-12
Sun Pharmaceuticals INR 234.15B 52.21B 2025-09
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12